# Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment :  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-rhinosinusitis-with-nasal-polyps-developing-drugs-for-treatment-guidance-for-industry/439c0f16-253a-4864-95f1-2bc1395e5163

> FDA guidance document: Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment :  Guidance for Industry. Issue date: June 28, 2023. Get complete insights and analysis.

---

## Details

- Title: Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-06-28
- Last Changed: 2025-01-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-1096">FDA-2021-D-1096</a>

## Related Documents

- [Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-drug-interaction-assessment-for-therapeutic-proteins-guidance-for-industry-guidance-for-industry/2a0a5163-7a5f-4b3c-9eef-d94d670b6733)
- [Benefit-Risk Assessment for New Drug and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/benefit-risk-assessment-for-new-drug-and-biological-products/90bf84f4-05cf-4617-b13d-bbb345349aed)
- [Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/amyotrophic-lateral-sclerosis-developing-drugs-for-treatment-guidance-for-industry-guidance-for-industry/933cd61f-72c5-470a-b6e9-21c7a3253529)